MPECT Home

Welcome to the next generation of the regulatory compliance platform

Collaborative, On Demand, Cross Platform

Smart Assessment, Virtual and Augmented Reality, Compliance Marketplace

Blockchain, Big Data Visualization, Predictive Analytics

Our Mission

To build a new class of regulatory compliance solutions that are proactive, collaborative and streamline the regulatory process.

Everyone on the same page

Communicate without email

Work together anywhere

Working hard at making compliance proactive

Mpect was born because our compliance processes are currently set up for a reactive approach. We saw a way to fix that approach. Unseating outdated solutions is no small job, and it takes a special platform to get it done. Mpect's Mobile platform is designed from the ground up to maximize collaboration, minimize risk and create a more effective team.

Smart assessments and reviews

Mpect Smart Assessments provides a Collaborative platform to review assets, standards and materials to stay true to regulation. Mpect solutions help companies collaborate internally with real-time monitoring and mentoring.

Connected Community

Mpect is built on a simple principle of collaboration— regulatory professionals helping each other with real time communication via our chat platform and sharing knowledge on regulatory requirements.

Knowledge and Learning

Using MPECT as a regulatory wiki, Mpect has a built platform for Regulatory & Compliance knowledge. This platform will centralize information, individual projects, and group communications.

News and Blogs

Mpect provides its users with access to regulatory news and a platform to share their thoughts, ideas and knowledge via their own blogs.

On Demand Collaborative Platform for Regulatory Compliance

The Pharmaceutical and Life Sciences & Healthcare industries are among the most heavily regulated industries in the world. The regulatory environment is continuously changing in response to the effects of globalization and harmonization, emerging markets, increasing complexity of disease targets, the introduction of new technologies and the rising sophistication and demands of both patients and regulators.